The Distribution of the Anticancer Drug Doxorubicin in Relation to Blood Vessels in Solid Tumors

Abstract

Limited distribution of doxorubicin in solid tumors is an important and neglected cause of clinical resistance that is amenable to modification. The technique described here can be adapted to studying the distribution of other drugs within solid tumors and the effect of strategies to modify their distribution.